Ken Pennline, Ph.D

Managing Partner

Dr. Ken Pennline, obtained his PhD in Immunology from The Ohio State University in 1977. His professional experience began as a faculty member in the Department of Pathology, Georgetown University (5 years) before he joined Pharma as a Senior Principal Scientist and Director of Core Flow Cytometry for Schering Plough (12 years). Dr. Pennline then joined Esoterix in 1997 where he held several positions including Global Director of Operations in Oncology/Cell Analysis and Vice President of Scientific Affairs where he promoted the scientific capabilities in business development efforts globally. After the acquisition by Labcorp in 2005, he became Vice President of Sales and Marketing assuming the lead role for integrating and then managing the business development and marketing teams for the combined Clinical Trials organization from 2005-2009.

In 2009 he was appointed to Vice President and Global Head of Laboratory Operations for LabCorp Clinical Trial Services. From 2011-2015 he held the position of Vice President and Global Head of Cytometry Services for the LabCorp Clinical Trial Services leading the advancement of this technology in novel drug development. Following the merger of Labcorp and Covance in 2015 he served as Executive Director and Global Head Cytometry Services for Covance Central Labs Services until May 2017.

Positions and Experience

Assistant Professor of Pathology, Co-Director Transplant Immune Monitoring Lab
- Georgetown University: 1981-1984
Senior Principal Scientist, Director Core Flow Cytometry Facility
- Schering-Plough: 1984-1997
Director Oncology/Cell Analysis, Executive Director Technical Support
- Esoterix Clinical Trial Services: 1997-2002
Vice President Scientific Affairs
- Esoterix Clinical Trial Services: 2001-2005
Vice President Global Sales and Marketing
- Laboratory Corporation of America, Esoterix Clinical Trial Services: 2005-2009
Vice President Global Laboratory Operations
- Laboratory Corporation of America, Esoterix Clinical Trial Services: 2009-2011
Vice President and Global Head Flow Cytometry Services
- Laboratory Corporation of America, LabCorp Clinical Trial Services: 2011-2015
Executive Director and Global Head Flow Cytometry Services
- Laboratory Corporation of America, Covance Central Lab Services: 2015-2017
Consultant, Managing Partner
- RED (Reliability Execution Development): 2018-Present

Our Team of Experts

Dennis Grimaud

Chief Executive Officer

Andrew Sloane

Chief Financial Officer

Keith Shults

Managing Partner

RED is a team of health industry veterans bridging the disconnect between wisdom and innovation for the biosciences and health services community by providing the guidance, connections and critical information new companies need to be successful.